Use Caution with Wikipedia

Use Caution with Wikipedia

US scientists undertook a comparison for entries in Wikipedia concerning conditions such as heart disease and lung cancer and compared…

More...
Pesticides Linked to NHL

Pesticides Linked to NHL

Findings from a study undertaken by the International Agency for Research on Cancer in France show that there is a…

More...
CLL and Combination Therapy

CLL and Combination Therapy

A phase II study was undertaken to examine the effectiveness of rituximab and lenalidomide in patients with chronic lymphocytic leukaemia…

More...
Pretreated Refractory HL

Pretreated Refractory HL

In this video, Dr. Filip Janku, from the University of Texas MD Anderson Cancer Center, discusses the findings of a…

More...
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

Healthcare Matters

  • 1
  • 2
  • 3
Prev Next

A Peek at AIL (Italy)

For the last 20 years, Maria Rita Grattarola has been involved with the Italian Association against leukemia-lymphoma and myeloma (AIL). Prior to joining AIL, Maria Rita was a business teacher. Initially, she volunteered for AIL and over the 20 years Maria Rita has been involved with the organisation, she has worked in many different areas. For the last 10 years, she’s been mostly responsible for organising patient seminars and patient groups.

Read more

Leukaemia & Blood Cancer New Zealand

Being a chief executive officer (CEO) comes with many responsibilities as Pru Etcheverry, CEO of Leukaemia & Blood Cancer New Zealand (LBC), can attest. “Every day is different but key responsibilities are income generation and financial management, leadership, brand building and positioning, service delivery for patients and families, and looking at organisational sustainability,” said Pru.

Read more

State of Healthcare in India

India is a country of more than 1.2 billion people comprising 28 states and seven union territories. There are 14 official languages in addition to Hindi and English, and within those languages numerous dialects. Consequently, it’s not surprising that India’s healthcare system is somewhat reflective of these differences: each state and union territory has its own healthcare system with its own healthcare priorities and medical schemes.

Read more

Latest Lymphoma News

  • HL and Primary Malignancies

    The risk, localisation and timing of third malignancies in 3,122 five-year survivors of Hodgkin lymphoma were assessed. Patients in this cohort were diagnosed before age 51 years and received treatment between 1965 and 1995.


    Read more...
  • Ofatumumab and CLL

    Ofatumumab plus chlorambucil has been approved in the USA as a first-line treatment for patients with chronic lymphocytic leukaemia (CLL) who cannot receive fludarabine-based therapy.


    Read more...

What's Happening Around the World

  • A Peek at CancerCare® (USA)

    As Chief Program and Communications Officer at CancerCare® in the USA, Brian Tomlinson has a lot going on. “I oversee all the mission programs. These include education, financial assistance and all of the clinical services as well as communications,” he said.

    Read more...  
  • Firefighter Sky Tower Challange Update

    In the April edition of the Node News newsletter, we focused on the work that Leukaemia & Blood Cancer New Zealand does. One of the fundraising events mentioned was the Firefighter Sky Tower Stair Challenge.

    Read more...  

Research

  • MZL and Ibrutinib

    Research is underway in some of the smaller subtypes of lymphoma. This phase II, open label non-randomised study is evaluating the safety and efficacy of ibrutinib in those with relapsed or refractory marginal zone lymphoma.

    Read more...  
  • Cladribine and CLL

    In this randomised phase III study, the efficacy and safety of cladribine and fludarabine, two purine analogues, were compared. Patients (n = 233) with chronic lymphocytic leukaemia were randomised to receive cladribine,

    Read more...  

 
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

IN THE NODE

Updates

  • What Not to Say to Patients

    Seven statements oncologists should never make when talking to patients.

  • Beleodaq Approved for PTCL

    The Food and Drug Administration in the USA has approved beleodaq for relapsed or refractory peripheral T-cell lymphoma.

THANK YOU FOR TAKING THE 2014 GLOBAL PATIENT SURVEY. The survey is now closed.